News | Radiology Imaging | February 17, 2021

KA Imaging Announces Passing of Co-founder Sina Ghanbarzadeh

It is with great sorrow and sadness that KA Imaging reported that its co-founder, Sina Ghanbarzadeh, passed away February 15, 2020. He had been battling lymphoma for over a year, but never gave up the fight.

February 17, 2021 — It is with great sorrow and sadness that KA Imaging reported that its co-founder, Sina Ghanbarzadeh, passed away February 15, 2020. He had been battling lymphoma for over a year, but never gave up the fight.

The company noted that 10 years ago at age 22 Ghanbarzadeh arrived in Canada for a Master’s degree at the University of Waterloo, in search of a better future. He was part of the nascent Silicon Thin-film Applied Research (STAR) group at Waterloo with Professor Karim, where early research on the X-ray technologies that would later originate KA Imaging started. Ghanbarzadeh was unique in that with only a research concept, he took the leap (along with others from the STAR group) to develop and pursue an idea to see it become reality.

Alongside Karim S Karim and Amol Karnick, Ghanbarzadeh helped found KA Imaging in 2015. His heart and soul were committed to the development of the Reveal detector, known for its breakthrough technology. Ghanbarzadeh helped transform KA Imaging from a small group of three founders a few years ago to a vibrant company producing one of the most innovative X-ray solutions in the world, one that he was instrumental in realizing. His dedication and commitment to ensuring that KA delivered a product that both, met customer needs and had exacting quality, drove the rest of the team. Beyond Reveal, he influenced all products at KA Imaging — he had even done some of the early work on selenium technology in the STAR group and contributed to the development of inCiTe and BrillianSe. Ghanbarzadeh was unrelentless and only through his hard work, not only do we have products but a company with a strong foundation. While dedicating himself to KA Imaging, he also remained committed to his Ph.D. degree at the University of Waterloo, diligently going through all the milestones. He was about to finish his thesis when he found out about the lymphoma. The cancer, unfortunately, advanced beyond treatment.

Amol Karnick, President and CEO of KA Imaging, and Karim S Karim, CTO of KA Imaging, stated on its website: “Sina was both a close friend and professional colleague and we are personally devastated that he is gone. Sina was extraordinary – he will be missed, but never forgotten. People come and go in our lives, but only a few make an impact. For us, Sina was one of those people who made a lasting impression. There will be those who never had the good fortune to meet Sina, however, they will know who he is, since his contribution will be everlasting.”

For more information: www.kaimaging.com

Related Content

A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Image used with permission of RSNA.

A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Read more about this case study. Image used with permission of RSNA.

Feature | Coronavirus (COVID-19) | April 09, 2021 | By Dave Fornell, Editor
While the mass COVID-19 vaccinat
3-D mammography reduces the number of breast cancer cases diagnosed in the period between routine screenings, when compared with traditional mammography, according to a large study from Lund University in Sweden. The results are published in the journal Radiology.

Getty Images

News | Breast Imaging | April 09, 2021
April 9, 2021 — 3-D mammography reduces the number of breast cancer cases diagnosed in the period between routine scr
IV contrast-enhanced 2-mSv 4-mm-thick transverse and coronal (b) CT images show inflamed diverticula (arrows), segmental colonic wall thickening, and adjacent pericolic fat stranding. Image courtesy of the American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

IV contrast-enhanced 2-mSv 4-mm-thick transverse and coronal (b) CT images show inflamed diverticula (arrows), segmental colonic wall thickening, and adjacent pericolic fat stranding. Image courtesy of the American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Computed Tomography (CT) | April 09, 2021
April 9, 2021 — According to an open-acc...
Futuristic campus design of Siemens Healthineers in Bengaluru, India.

Futuristic campus design of Siemens Healthineers in Bengaluru, India.

News | Radiology Business | April 08, 2021
April 8, 2021 — Siemens Healthineers announced t
Varian announced it is collaborating with Google Cloud to build an advanced artificial intelligence (AI) based diagnostic platform to aid in the fight against cancer. Varian and Google Cloud AI embarked on a deployment journey, using Neural Architecture Search (NAS) technology via Google Cloud AI Platform, to create AI models for organ segmentation — a crucial and labor-intensive step in radiation oncology that can be a bottleneck in the cancer treatment clinical workflow.
News | Artificial Intelligence | April 08, 2021
April 8, 2021 — Varian announced it is collaborating with Google...
Mobidiag Oy, a privately held, commercial-stage Finnish-French developer of innovative molecular diagnostic tests and instrumentation, announced today that it has signed a definitive agreement to be acquired by Hologic, Inc., a global leader in women's health, for an enterprise value of approximately $795 million.  This includes a cash payment of approximately $714 million for Mobidiag’s equity, and net debt of approximately $81 million.
News | Women's Health | April 08, 2021
April 8, 2021 — Mobidiag Oy, a privately held, commercial-stage F
Axial chest CT examination in a 54-year-old participant. A, On the axial noncontrast chest CT image, the pectoralis muscle (PM) area was segmented and measured in the section above the aortic arch. B, The subcutaneous adipose tissue (SAT) area as the area between the PM and the skin surface on the same section was also measured and the attenuation of pixels in the SAT area was used to determine the individualized threshold for the intermuscular adipose tissue (IMAT). C, The IMAT within the PM was segmented

Axial chest CT examination in a 54-year-old participant. A, On the axial noncontrast chest CT image, the pectoralis muscle (PM) area was segmented and measured in the section above the aortic arch. B, The subcutaneous adipose tissue (SAT) area as the area between the PM and the skin surface on the same section was also measured and the attenuation of pixels in the SAT area was used to determine the individualized threshold for the intermuscular adipose tissue (IMAT). C, The IMAT within the PM was segmented as the areas with Hounsfield units below this threshold for the IMAT (arrowheads). Image courtesy of the Radiological Society of North America

News | Computed Tomography (CT) | April 07, 2021
April 7, 2021 — Body composition information derived from routine chest...
Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal

Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal

News | Artificial Intelligence | April 06, 2021
April 6, 2021 — In 2020, the International Agency for Research on...
Nano-X Imaging Ltd (Nanox), an innovative medical imaging technology company, announced that its single-source Nanox.ARC digital x-ray technology has received 510(k) clearance from the US Food and Drug Administration.
News | X-Ray | April 02, 2021
April 2, 2021 — Nano-X Imaging Ltd.